Silver Lining Textiles Launches Technical Medical Uniform Designed to Reduce Bacteria
Silver Lining Textiles (SLT)Â launches UNDER SCRUB, a medical technical base layer that kills the bacteria that causes infection, with hopes of reducing transmission from patient to patient.
UNDER SCRUB announces its use of innovative yarn technology in the weaving of a protective base layer to help fight the spread of hospital-acquired infections. Products are available exclusively at the company's e-commerce site www.underscrub.com.
"We've done extensive research and development to create a product with superior efficacy against commonly occurring bacteria encountered in both hospitals and the community," says Jason Katsapetses, founder and CEO of SLT. "Independent test results consistently demonstrate rapid and massive reduction of bacteria within minutes of exposure to our highly technical fabric."
UNDER SCRUB is one of the first revolutionary base layers with antimicrobial, anti-fungal and anti-odor properties that are embedded "within the yarn," thus remaining effective for the life of the garment. This new yarn technology, using natural elements, is designed to deliver extreme permanent protection, unlike harsh chemical finishes that are applied topically.
Kevin Young, MD, SLT's medical director, notes, "We speculate that this innate antimicrobial ability could dramatically reduce the risk of nosocomial infection and microbial transmission both in the hospital and the community. This would reduce risk without any active participation by the healthcare provider wearing our technical fabrics. Unlike handwashing, this product does not require someone following protocol."
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
